Last update :
03/05/2024
Antibiotic   Ciprofloxacin lactate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Aristin C Greece
Baycip Chile, Spain, Sweden
Cepokab Mexico
Ciflosin Turkey
Ciflox France, Saudi Arabia
Cifloxin Chile, Colombia, Malaysia
Cifoblas Colombia
Cifran India
Ciprine India, Switzerland
Ciprinol Croatia, Poland, Romania
Ciprivax Venezuela
Cipro Canada, Turkey, United States of America
Ciprobay Croatia, Germany, Hungary, Saudi Arabia, Slovenia, United Arab Emirates
Ciprobid India
Ciproflox Mexico
Ciprofloxacin Austria, Canada, Denmark, Finland, Germany, Great Britain, Greece, Hungary, Italy, Netherlands, Norway, Poland, Sweden
Ciprofloxacina Argentina, Colombia, Portugal, Romania, Venezuela
Ciprofloxacine Belgium, Morocco, Switzerland
Ciprofloxacino Chile, Colombia, Spain
Ciprohexal Germany
Ciproktan Turkey
Cipromed Croatia
Ciproxan Japan
Ciproxin Australia, Austria, Great Britain, Greece, Italy, Sweden, Switzerland, Turkey
Ciproxina Ecuador, Mexico, Portugal, Venezuela
Ciproxine Belgium, Luxembourg, Morocco, Switzerland
Ciproxino Chile
Cisplatin
Citeral Croatia
Estecina Spain
Ladinin Malaysia
Nafloxin Greece
Proxacin Poland
Topistin Greece
Truoxin Ireland
Stability of mixtures   Injection   Stability of mixtures : Ciprofloxacin lactate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Gentamicin sulfate 1 mg/ml
25°C
48 Hour
Light 434
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Tobramycin sulfate 1 mg/ml
25°C
48 Hour
Light 434
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Amikacin sulfate 1,5 mg/ml
25°C
48 Hour
Light 434
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Metronidazole 4 mg/ml
25°C
48 Hour
Light 434
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Gentamicin sulfate 1 mg/ml
4°C
48 Hour
Protect from light 434
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Tobramycin sulfate 1 mg/ml
4°C
48 Hour
Protect from light 434
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Metronidazole 4 mg/ml
4°C
48 Hour
Protect from light 434
Polyvinyl chloride Sodium chloride 0,9% 1,5 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Amikacin sulfate 1,5 mg/ml
4°C
48 Hour
Protect from light 434
Polyolefine None 4 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Linezolid 2 mg/ml
23°C
7 Day
Protect from light 1668
Level of evidence C+
Polyolefine None 4 mg/ml
Injection   Ciprofloxacin lactate   
Injection   Linezolid 2 mg/ml
4°C
24 Hour
Protect from light 1668
Level of evidence C+

  Mentions Légales